lymphocytes

New therapeutic frontiers for Multiple Sclerosis

From personal experience I have been able to verify that in recent years Multiple Sclerosis (MS) increasingly affects early onset, therefore very young people, but I have also been able to appreciate, having worked in a Research and Treatment Center for Multiple Sclerosis, that State-of-the-art therapies visually slow its progression, thus also increasing the quality… Continua a leggere New therapeutic frontiers for Multiple Sclerosis

2022-12-28Marketing